In prostate cancer, menin has been identified as an important co-factor for androgen receptor (AR) signaling by direct interaction with the N-terminal domain of the AR and recruitment of the MLL histone methyltransferase activity [9]. This evidence concerns the gene KMT2A and prostate cancer.